Sensitive high-performance liquid chromatographic assay using 9-fluorenylmethylchloroformate for monitoring controlled-release lidocaine in plasma
dc.contributor.author | Sintov, Amnon | en_US |
dc.contributor.author | Siden, Rivka | en_US |
dc.contributor.author | Levy, Robert J. | en_US |
dc.date.accessioned | 2006-04-07T20:58:24Z | |
dc.date.available | 2006-04-07T20:58:24Z | |
dc.date.issued | 1989 | en_US |
dc.identifier.citation | Sintov, Amnon, Siden, Rivka, Levy, Robert J. (1989)."Sensitive high-performance liquid chromatographic assay using 9-fluorenylmethylchloroformate for monitoring controlled-release lidocaine in plasma." Journal of Chromatography B: Biomedical Sciences and Applications 496(): 335-344. <http://hdl.handle.net/2027.42/28181> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6TG9-44CGPXY-15/2/d8198066927d40e681215667e79778bd | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/28181 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2613837&dopt=citation | en_US |
dc.description.abstract | A sensitive high-performance liquid chromatographic (HPLC) assay using fluorescence detection for quantifying lidocaine levels in plasma (in the ng/ml range) was developed. This novel HPLC assay has made possible the simultaneous monitoring of lidocaine levels in coronary and peripheral plasma obtained after myocardial controlled-release matrix administration (0.92 mg/kg during 4 h) in the arrhythmic dog. The method employed extracts the drug from plasma using 1-chlorobutane and a subsequent derivatization with 9-fluorenylmethylchloroformate in acetonitrile at 110[deg]C. The derivative was chromatographed on a C18 reversed-phase column and measured with fluorescence detection (excitation 254 nm, emission 313 nm). N-Methylephedrine was found to be suitable as an internal standard, post-derivatization. The derivatization product of lidocaine was identified and characterized by mass spectral analysis. It was found to have a unique and reproducible dicarbamate structure, which was stable for at least three days at room temperature. The method was tested with human plasma as well as on dog plasma. Analytical recoveries were 88.6 +/- 3.6 and 77.4 +/- 3.0% (mean +/- S.E.), respectively, at levels ranging from 25 to 200 ng/ml. The lower detection limit was 1 ng/ml lidocaine. In conclusion, this rapid and convenient analysis was found to be suitable for the bioavailability pharmacokinetic assessment of lidocaine following low-dose regional drug administration. | en_US |
dc.format.extent | 681105 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Sensitive high-performance liquid chromatographic assay using 9-fluorenylmethylchloroformate for monitoring controlled-release lidocaine in plasma | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemical Engineering | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pediatrics, C.S. Mott Children's Hospital, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 U.S.A.; Department of Pharmaceutics, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pediatrics, C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, MI 48109 U.S.A. | en_US |
dc.contributor.affiliationum | Division of Pediatric Cardiology, C.S. Mott Children's Hospital, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 U.S.A.; Department of Pharmaceutics, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 U.S.A. | en_US |
dc.identifier.pmid | 2613837 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/28181/1/0000633.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/S0378-4347(00)82581-5 | en_US |
dc.identifier.source | Journal of Chromatography B: Biomedical Sciences and Applications | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.